FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is weighing approval for Moderna's mRNA-based flu vaccine. If cleared, it would be the first mRNA flu shot to reach the market, and per NPR, the decision could ripple through the biotech industry.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton